← feed

Is NCT03141658 results overdue?

Yes — results are overdue. Primary completion was 2018-04-04; the FDAAA-801 reporting deadline (2019-04-04) passed 2681 days ago and no results are posted on ClinicalTrials.gov.

Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects

NCT IDNCT03141658 ↗
SponsorTaisho Pharmaceutical R&D Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-04-04 (ACTUAL)
Reporting deadline2019-04-04 (completion + 365d)
Days overdue2681
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 72124ff17ffef386… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03141658. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →